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LIST OF ABBREVIATIONS 
AMP Adenosine-5'-monophosphate 
ATP Adenosine-5'-triphosphate 
CD Circular dichroism 
CMDPL Carboxymethyl-deoxypyridoxal 
DPL Deoxypyridoxal 
EDTA Ethylenediaminetetra-acetate 
G-HCl Guanidine hydrochloride 
glycero-P Glycerophosphate 
G-l-P a-D-Glucose-l-phosphate 
G-6-P Glucose-6-phosphate 
3-ME 3-Mercaptoethanol 
PL Pyridoxal 
PLP Pyridoxal-5'-phosphate 
PMB Para-Hydroxymer curibenzoate 
PMP Pyridoxamine-5'-phosphate 
UDPG Uridine-5'-diphosphoglucose 
UV Ultraviolet 
SDS Sodium dodecyl sulfate 
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GENERAL INTRODUCTION 
Glycogen in animals is synthesized and degraded by two 
separate enzyme systems. The degradative enzyme is glycogen 
phosphorylase (E.G. 2.4.1.1., a-1,4-v/lucan:orthophosphate 
glucosyl transferase). The following scheme illustrates the 
reaction catalyzed by the enzyme. 
phosphorylase 
orthophosphate a-D-glucose-l-phosphate 
+ + 
n(a-l,4 linked glucosyl n-l(a-l,4 linked glucosyl 
residues) residues) 
This reaction is freely reversible, and can easily be studied 
in vitro in either direction. 
Phosphorylase is present in animal tissue in two forms 
designated a and b. The two forms are interconvertible, and 
the process by which the interconversion takes place is shown 
in the scheme. 
phosphorylase kinase 
Mg2+,ATP 
phosphorylase b ^ phosphorylase a 
phosphorylase phosphatase 
In the interconversion reaction two specific seryl residues 
are phosphorylated per mole of phosphorylase b by a specific 
kinase to produce phosphorylase a. The a form of the enzyme 
can be converted back to the b form by a specific phosphatase. 
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Phosphorylase a and b differ in their expression of enzymatic 
activity^ Phosphorylase b requires the presence of the nucleo­
tide adenosine-5'-phosphate for enzymatic activity. Phos­
phorylase a is active enzymatically without this activator 
being present. The currently accepted molecular weights for 
the two forms of phosphorylase in rabbit skeletal muscle are 
370,000 for a and 185,000 for b (Seery et al., 1967). 
The most enigmatic aspect of the phosphorylase system is 
presence of covalently bound pyridoxal-5'-phosphate. There are 
two moles of PLP per mole of phosphorylase b. Removal of the 
PLP under specific conditions causes the loss of enzymatic 
activity, and reconstitution of the apoenzyme with PLP restores 
the enzymatic activity. This thesis presents new data on PLP 
in phosphorylase. PLP analogues have been used to gain more 
information about the mode of binding of the coenzyme and the 
functional groups of the coenzyme itself that are necessary 
for expression of enzymatic activity. Spectral data are 
presented that give further information about the binding site 
for PLP in phosphorylase. 
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LITERATURE REVIEW 
Introduction 
It has now been just over a decade ago that pyridoxal-5'-
phosphate was first discovered in glycogen phosphorylase from 
rabbit skeletal muscle (Baranowski et , 1957). Since that 
time, much, data has accumulated concerning PLP in phosphorylase. 
This review will attempt to examine all published data on the 
subject including the author's own published data. This has 
been done in order to make the literature review a complete 
entity that will stand by itself. The experimental section of 
the thesis will therefore be concerned primarily with the un­
published data of the author. It is hoped that this review 
will prove useful to those who will follow. 
Occurrence of PLP in Glucosyl Transferases 
Baranowski et al. (1957) reported that two moles of PLP 
were bound per mole of crystalline phosphorylase b.^ This 
value would have to be considered somewhat less than stoichio­
metric, since the old molecular weight of 242,000, determined 
by Keller and Cori (1953) was used. However, Kent et al. (1958) 
reported 2.5 + 0.2 moles of PLP per 250,000 g of phosphorylase 
b. This observation along with the redetermined molecular 
^Unless specifically noted, the designations phosphorylase 
a and b used in this review will refer to the enzyme from 
rabbit skeletal muscle only. 
I 
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weight for phosphorylase b of 185,000 reported by Seery et al. 
(1967) would give 1.9 moles of PLP per mole of phosphorylase b. 
Since the time PLP was first reported in the glycogen 
phosphorylase of rabbit muscle, it has been subsequently found 
in the polyglucose phosphorylases of many diverse organisms as 
well as in phosphorylases of different tissues of the same 
organism. For example, PLP has been found in the polyglucose 
phosphorylases of E. coli (Schwartz and Hofnung, 1967; Chen and 
Segel, 1968), lobster (Cowgill, 1959), and potato (Lee, 1960). 
The glycogen phosphorylases of rabbit heart (Yunis et al., 
1962), rabbit liver, (Appleman et a^., 1966), and bovine kidney 
(Villar-Palasi and Gazquez-Martinez, 1968) all contain PLP. 
In all the cases cited, the presence of PLP was determined 
spectrophotometrically by either observing the spectrum of the 
native enzyme directly, or the spectrum of an extract of the 
enzyme under acidic or basic conditions. 
An alternative method of detecting the presence of PLP in 
a phosphorylase is the pyridoxine deficiency test. By using 
animals which require pyridoxine for growth, and then depriving 
them of this substance, a deficiency can be induced. This 
deficiency can then be correlated with a decrease in the 
measured activity of an enzyme that requires PLP. Usually the 
activity of an enzyme which is known not to require PLP is also 
measured as a control. Using pyridoxine deficient rats 
Illingworth et a^. (1960) showed that total muscle phosphorylase 
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activity (a + b) undergoes a marked drop (35%) over the control 
group of rats which were fed pyridoxine. The phosphorylase a 
activity, however, remained relatively constant, and if only 
the a activity had been measured, an erroneous conclusion 
might have been reached. In this same study, the enzymatic 
activity of glycogen synthetase (UDPG: a-l,4-glucan a-gluco-
syltransferase) was also measured, and because no change was 
found in the activity of this enzyme, it was tentatively con­
cluded that PLP was not required for this enzyme. This con­
clusion is equivocal, however because it is now known that 
the synthetase exists in two forms, one of which is inactive 
without the presence of glucose-6-phosphate. The assay of 
Illingworth et a2. did not include this activator. If the, 
pyridoxine deficiency test is negative, the result must be 
accepted with some reservation. Lyon and Porter (1962) pre­
sented data that indicated that pyridoxine deficiency did not 
decrease the activity of liver phosphorylase. This is in 
contrast to the study of Eisenstein (1962) whose data show that 
liver phosphorylase activity does indeed decrease in deficient 
rats, but the decrease is not as marked as is found with the 
muscle enzyme. This was interpreted to mean that the liver 
enzyme turned over slower than the muscle enzyme. The pyri­
doxine deficiency test has been used to implicate the presence 
of PLP in the glycogen phosphorylases of the heart, brain 
(Valadares, 1967) and adrenal glands (Tiglao and Eisenstein, 
1964) of the rat. Obviously, direct assays for PLP on highly 
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purified enzyme preparations is the most preferable method, 
but the pyridoxins deficiency test does provide useful prelim­
inary data which can help direct more concentrated effort. 
The only types of glucosyl transferases that have been 
shown to require PLP are those that catalyze the phosphorolysis 
of an a-1,4 linked polyglucose chain to produce a-D-glucose-
1-phosphate. It would be very significant if an enzyme of this 
type were found that did not require PLP for activity. This 
would rule out any obligatory requirement for PLP in the mech­
anism of action of this kind of glucosyl transferase. There 
has not as yet been any polyglucose phosphorylase with this 
stereochemical, retention type of mechanism isolated that did 
not contain PLP. There are also polyglucose:phosphorylases 
with mechanisms that involve inversion of configuration during 
catalysis. The 3-1,3-oligoglucan:orthophosphate glucosyl 
transferase from Euglena gracilis (Maréchal, 1967b) and the 
g-l,4-oligoglucan:orthophosphate glucosyl transferase from 
Clostridium thermocellum (Sheth and Alexander, 1969) are of this 
type. Whether these inversion polyglucose phosphorylases are 
related in an evolutionary sense to the retention type is not 
known, but if they are related, they might also require PLP for 
activity. These enzymes have not yet been investigated to 
determine whether PLP is bound as a prosthetic group. 
The only other glucosyl transferases that utilize ortho-
phosphate, and that might contain PLP are the disaccharide 
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phosphorylases, which can also be classified according to 
retention or inversion of configuration during catalysis. Su­
crose phosphorylase is the only one that gives retention, and 
its mechanism has been shown to be ping-pong (Silverstein 
et al., 1967). This is in direct contrast to all other phos- . 
phorylases which appear to show ternary complex mechanisms. 
The inversion disaccharide phosphorylases include maltose 
phosphorylase, which is specific for g-D-glucose-l-phosphate, 
cellobiose phosphorylase (Doudoroff, 1961), and laminaribose 
phosphorylase (Maréchal, 1967a). Again, none of these enzymes 
have been critically examined in purified form for PLP. 
A glucosyl transferase that might be related to glycogen 
phosphorylase is glycogen synthetase which is a UDPG;a-l,4-
glucan a-4-glucosyl transferase. In analogy to the mammalian 
glycogen phosphorylase a, the glycogen synthetase also exists 
in a phosphorylated form., Larner and Sanger (1965) have 
isolated a hexapeptide containing the phosphoseryl residue from 
rabbit and rat muscle glycogen synthetase that is identical to 
the one isolated from phosphorylase a (Krebs and Fischer, 1962). 
This homology implies that the two proteins might be closely 
related in more than just this short sequence. As was previ­
ously indicated, the pyridoxine deficiency test proved negative 
for PLP involvement in this enzyme, but because of the inade­
quacy of this test, it is imperative that a purified prepara­
tion of this enzyme be tested directly for PLP. 
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No evidence has been presented that would indicate that 
phosphorylase has been derived from a more normal PLP contain­
ing enzyme. Hedrick and Fischer (1965) examined phosphorylase 
b and a closely for residual PLP enzyme activities. They 
found no transaminase, decarboxylase, or g- and y-elimination 
activities characteristic of PLP enzymes. Their attempts to 
construct a nonenzymic model system were also negative. 
Preparation and Properties of the Apoenzyme 
The first preparation of apophosphorylase was reported by 
Cori and Illingworth (1957). The procedure, which could be 
used with either phosphorylase a or b, involved precipitation 
of holoenzyme with cold HCl in the presence of ammonium sulfate, 
centrifuging, and then washing the yellow precipitate a few 
times with alkaline cimmonium sulfate to remove the PLP. The 
apoenzyme that was prepared could be reactivated to a sub­
stantial extent by excess PLP. If a lower pH were used in the 
acid precipitation, a greater specific activity of the recon­
stituted apoenzyme was obtained, but the loss of total enzyme 
to denaturation was greater. Illingworth et al. (1958) sub­
sequently developed a new procedure for apo-b that resulted in 
better yield and reactivation by PLP. Phosphorylase b was 
dialyzed for 12 hours at 0® against pH 6.0 glycerophosphate 
buffer in the presence of L-cysteine to give apo-bl If phos­
phorylase a was treated in a similar manner, no resolution 
took place. 
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A better method was also found for the preparation of 
apo-a. To phosphorylase a in the presence of cysteine was 
added concentrated citrate buffer at pH 3.5; after a few 
minutes of reaction time at 0°, the apoenzyme was precipitated 
with alkaline ammonium sulfate, centrifuged, and washed. Dial­
ysis against pH 7.4 thioglycolate buffer in the cold gave 
crystalline apo-a (Illingworth et ^. ). The apo-a gave two 
principal peaks in the ultracentrifuge with sedimentation 
constants characteristic of monomeric and tetrameric forms of 
phosphorylase. Reconstitution with PLP gave an ultracentrifuge 
pattern characteristic of holo-a, showing only the tetrameric 
form. Apo-b, however, showed only one broad peak in the ultra-
centrifuge which sharpened on reconstitution with PLP with 
little change in sedimentation constant. 
The most useful procedure for preparation of apo-b has 
been described by Shaltiel et (1966). Phosphorylase b is 
reacted with L-cysteine in the presence of an imidazole-citrate 
buffer at pH 6.2 and 0°. The resolution is complete with the 
conditions employed in about one-half hour. The resolved 
enzyme is then precipitated with ammonium sulfate and desalted 
on a Sephadex column. The apo-b made by this procedure can be 
2+ 
crystallized, but only in the presence of Mg , AMP and 
3-mercaptoethanol. The apoenzyme usually shows a specific 
activity of 0.1-1.0% of the original holoenzyme. This resid­
ual activity correlates well with residual bound PLP as 
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determined by spectrophotometric means. The correlation 
suggests that within experimental error, the apoenzyme is 
enzymatically completely inactive. 
The resolution procedures that have been outlined utilize 
the same general steps. The enzyme is deformed by appropriate 
conditions in the presence of a PLP trapping reagent, cysteine, 
which removes the PLP from the enzyme as a thiazolidine 
derivative. This adduct will not recombine with the apoenzyme 
in the presence of the deforming agents. 
Shaltiel et a2. have extensively studied the mechanism 
by which their resolution procedure takes place. In the 
32 presence of the imidazole buffer, [ P] PLP free in solution 
was found to be readily exchangeable with PLP on the enzyme, 
a condition that did not occur in the absence of the buffer. 
Ultracentrifuge studies showed a SgQ ^  of 5.5 in the presence . 
of the imidazole-citrate buffer at pH 6.0, iip contrast to a 
^20 w 8.4 in the presence of glycerophosphate buffer. Dial­
ysis reversed the change in sedimentation constant. The Sgg ^ 
of 5.5 is very close to that of PMB induced monomer reported 
by Madsen and Cori (1956), and it was concluded by Shaltiel 
et al. that imidazole-citrate buffer induces monomerization of 
dimer phosphorylase b. AMP which blocks monomerization com­
pletely blocked the resolution of b, and G-6-P, which inhibits 
monomerization, inhibited the resolution of b (Fischer et al., 
1968). In further support of the importance of monomer in 
I 
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resolution, Fischer and Krebs (1966) have indicated that PMB 
induced monomer can be resolved with hydroxylamine. The only 
negative evidence for the hypothesis that monomerization is a 
prerequisite to resolution is the observation that NaCl pro­
motes dissociation but blocks resolution (Shaltiel et al., 
1966) . 
Phosphorylase a was not resolved with the conditions 
employed for resolution of b. However, if glycogen were 
present, resolution took place (Fischer et a2., 1968). Gly­
cogen has been shown to promote the dissociation of tetramer a 
to dimer a (Wang and Graves, 1964; Metzger et , 1967) . 
Fischer et a^. (1968) have found conditions for phosphorylase a 
resolution without glycogen:hydroxylamine in the presence of a 
maleate-imidazole-citrate buffer at pH 5.5 and 22° is required. 
It has not been reported whether these conditions favor mono­
merization of a. 
Shaltiel et al. (1966) have shown that the resolution 
reaction is first order in L-cysteine, indicating that the 
protein is attacked directly by cysteine. The reaction shows 
considerable sterospecificityzD-cysteine is completely inactive 
in the resolution reaction. Hydroxylamine was the only alde­
hyde reagent that was as effective as L-cysteine. The fol­
lowing compounds were ineffective in bringing about resolution; 
cysteamine, homocysteine, g-mercaptopropionic acid, ethylene 
diamine, sodium bisulfite, and S-methyl cysteine. Compounds 
that were poorer resolving agents than L-cysteine included 
12 
penicillamine,2,3-dimercaptopropanol, semicarbazide and 
isonicotinyl hydrazide. 
The apo-b made by the procedure of Shaltiel et (1966) 
was most stable at pH 6.0 in the presence of AMP. While the 
apo-b is relatively stable below 30°, it rapidly denatures at 
elevated temperatures, showing much more heat instability than 
the native enzyme. Apo-b appears as a rapidly associating-
dissociating system in the ultracentrifuge (Hedrick et a2., 
1966) . From the observed sedimentation constants, the apo-
enzyme sediments as a monomer at 35°, a dimer at 23°, and as a 
tetramer or higher aggregates near 0°. Holophosphorylase b 
remains a dimer throughout this temperature range. Hedrick 
et al. observed that AMP favors aggregation of the apo-b, 
proving that AMP will still bind to the apoenzyme. High con­
centrations of NaCl (1-3M) also favored aggregation of apo-b. 
Kastenschmidt et (1968) have done direct binding 
studies, using a gel filtration technique, on the interaction 
of AMP with apo-b, and have determined a dissociation constant 
-4 
of 5.3 X 10 ; under the same conditions, a dissociation con-
-4 
stant of 3.7 x 10 was determined for the holoenzyme. The 
cooperative binding of AMP characteristic of holo-b, however, 
is absent with apo-b. Apo-b was found by these same workers 
to bind the substrate glycogen as tightly as the holoenzyme. 
Illingworth et (1958) had previously demonstrated that 
apo-b could be converted to apo-a with phosphorylase kinase. 
This result was confirmed by Hedrick et al. (1966), and it was 
13 
further shown that apo- and holoenzymes were phosphorylated at 
similar rates by phosphorylase kinase. Removal of PLP from the 
enzyme does not therefore destroy the conformation at the seryl 
site required by phosphorylase kinase. 
Much of the experimental data available on the properties 
of apo-b is consistent with conformational changes taking place 
on removal of PLP from holoenzyme. These conformational 
changes are all reversible upon addition of PLP to the apo­
enzyme. Optical rotatory dispersion studies of Johnson and 
Graves (1966) indicate no significant changes in secondary 
structure between apo- and holoenzymes which is consistent with 
a limited conformational change involving secondary structure. 
It cannot be concluded from the observed properties of the 
apoenzyme that PLP has only a structural role in phosphorylase. 
The apoenzymes of other PLP enzymes also have properties 
distinct from their holoenzymes. Apotryptophanase, for example, 
exists as a tetramer which dissociates reversibly upon dilution 
or low temperatures to a dimer, whereas the holoenzyme stays as 
a tetramer under the same conditions (Morino and Snell, 1967). 
PLP may, in fact, have a structural role as well as a catalytic 
role in many of the normal PLP requiring enzymes. 
I 
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Effect of Coenzyme Structure on 
Binding and Activity 
Reconstitution of apoenzyme 
The reconstitution of apo-b with PLP has been studied by 
Hedrick et al. (1966). The reconstitution process was found 
to be quite temperature dependent. An Arrehnius activation 
energy of 22.3 Kcal/mole was obtained by following the return 
of enzymatic activity at different temperatures. Reconstitu­
tion seemed to be only slightly dependent on pH; in a series 
of experiments where the pH was varied from 5.0 to 8.0, 80-100% 
reactivation was obtained in all cases within three minutes at 
37°, and full reconstitution was obtained within nine minutes. 
The extent and rate of reconstitution was not effected by the 
following compounds; AMP, G-l-P, glycogen and glucose-6-
phosphate (Fischer et al., 1968). As was discussed earlier, 
both AMP and glucose-6-phosphate blocked the resolution process. 
Reconstitution was found to be inhibited in the presence of a 
large excess of PLP. This inhibition of reconstitution was 
not specific for PLP, since compounds such as formaldehyde, 
glyceraldehyde and pyridine-4-aldehyde also inhibited. The 
holoenzyme was much less sensitive to aldehyde inhibition than 
the apoenzyme. 
Surprisingly, L-cysteine even though it forms a stable 
complex with PLP does not block reconstitution, whereas its 
enantiomer, D-cysteine, is quite effective in blocking reconsti­
tution. Fischer et al. (1968) reported that 95% reactivation of 
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apo-b could be obtained with L-cysteine after 30 min at 30°, 
while only 3% reactivation was attainable with D-cysteine under 
the same conditions. Reconstitution in the presence of a large 
excess of L-cysteine was investigated using both and ^^S-
labeled cysteine (Fischer and Krebs, 1966). Ammonium sulfate 
precipitation followed by Sephadex chromatography gave a recon­
stituted enzyme with one mole of cysteine incorporated per 
mole of monomer. Apoenzyme treated in the same manner showed 
no incorporation of cysteine. The bound cysteine in the re­
constituted enzyme could be exchanged with unlabeled cysteine, 
however. Further investigation of cysteine binding to holo-
enzyme and enzyme reconstituted in the presence of cysteine is 
needed to establish the nature of the cysteine-enzyme complex. 
Illingworth et al. (1958) have reported a second order 
-1 -1 
rate constant of 185 M sec for the reaction of PLP with 
apo-b in 0.04 M sodium glycerophosphate, 0.005 M EDTA buffer at 
pH 7.0 and 25°. The reaction was followed by the decrease in 
absorbance at 390 nm with time. The value reported for the 
rate constant is probably in some error, since the old molecu­
lar weight for phophorylase b was used and the experimental 
procedure involved adding a stiochiometric amount of PLP to the 
apoenzyme. In contrast to apo b, the reconstitution of apo-a 
with PLP has been reported to be instantaneous at 15°C by 
Fischer e± (1968). It is not known whether the difference 
in rate for PLP binding to apo-a and apo-b has much physio­
logical importance. PLP could bind to either apo-a or b 
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in vivo. Lyon and Porter (1963) have reported a strain of 
mice that exhibit no phosphorylase kinase activity in their 
skeletal muscles. These mice, which appear normal, therefore 
have no apo-a, and only apo-b would be available for combina­
tion with PLP. 
Analogue studies 
A variety of PLP analogues have been tested for their 
ability to bind to apo-b and -a and to restore the enzymic 
activity once bound. The names and structural formulas of 
these analogues, along with their ability to restore enzymic 
activity can be found in Table 1. Illingworth et a^. (1958) 
demonstrated that incubation of apo-a with excesses of pyri-
doxal and 5-deoxypyridoxal gave reconstituted enzymes that were 
indistinguishable from the holoenzyme in the ultracentrifuge. 
A compound that lacks a 4-formyl group, pyridoxamine phosphate, 
had no effect on the sedimentation of apo-a. None of these 
derivatives gave any reactivation of the apoenzyme. Further 
evidence for the binding of pyridoxal and 5-deoxypyridoxal was 
obtained in reactivation experiments with PLP in the presence 
of varying amounts of these derivatives. 5-deoxypyridoxal was 
more effective than pyridoxal in preventing the reconstitution 
of the apoenzyme with PLP. Since pyridoxal exists mainly as a 
hemiacetal in solution (Martel, 1963; Metzler and Snell, 1955), 
it is not surprising that it is not as effective as 5-deoxy­
pyridoxal. Pyridoxamine phosphate was completely ineffective 
Table 1. Structure and activity of coenzyme analogues tested with apophosphorylase 
Structure Name R R' R" R"' Activates 
o 
CHO OH 
*"^3 J, 
A. Pyridoxal CH3 OH CHO CHgOH No 
B. 5-Deoxypyridoxal CH3 OH CHO CH3 No 
C. Pyridoxal sulfate CH3 OH CHO CH2OSO3H No 
D. Pyridoxine 
phosphate CH3 OH CHgOH CH2OPO3H2 No 
E. Pyridoxic acid 
phosphate CH3 OH COgH CH2OPO3H2 No 
F. Pyridoxamine 
phosphate CH3 OH CHgNHg CH2OPO3H2 No 
G • 4 - De oxy py r i dox i ne 
phosphate CH3 OH CH3 CH2OPO3H2 No 
H. 3-0-Methylpyridoxal 
phosphate CH^ OCH3 CHO CH2OPO3H2 Yes 
I. w-Methylpyridoxal 
phosphate CH3CH2 OH CHO CH2OPO3H2 ? 
J. N-MethyIpyridoxa1 
phosphate (See column I) No 
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in preventing reconstitution of apo-a by PLP. These results of 
Illingworth et a^. (1958) clearly indicate the role of the 4-
formyl group in coenzyme binding and the requirement of the 
5'-phosphate group for return of enzymatic activity after co­
enzyme binding. 
The most comprehensive recent investigations of PLP 
analogues and apophosphorylase have been reported by Fischer 
and Krebs (1966), and Fischer et al. (1968). In agreement with 
Illingworth et al. (1958), it was found that any replacement of 
the 4-formyl group resulted in a derivative with no capacity 
for reactivation. Pyridoxine phosphate, pyridoxamine phosphate, 
and pyridoxic acid phosphate, and 4-deoxypyridoxine phosphate 
all failed to reactivate the apoenzyme. All derivatives that 
lacked the 5'-phosphate group were also inactive. 5-carboxy-
methylpyridoxal and pyridoxal sulfate were in this category. 
Other substituents on the pyridine ring that could be involved 
in the ability of PLP to reactivate the apoenzyme include the 
3-hydroxy group, the 2-methyl group and the pyridine nitrogen 
itself. The role of the 3-hydroxy group was tested with 3-0-
methylpyridoxal phosphate. This derivative was found to re­
activate apo-b to 25% of that obtained with PLP, and apo-a to 
40-45% of the activity obtained with PLP. The 3-hydroxy group 
of PLP cannot therefore be involved in an obligatory protona-
tion-deprotonation step during enzymic catalysis. 
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Illingworth et (1958) reported that w-methylpyridoxal 
phosphate, the 2-ethyl analogue of PLP, gave 50% of the re­
activation that could be obtained with PLP and apo-b. Fischer 
et al. (1968) repeated this experiment with another sample of 
analogue and found no reactivation. It would be doubtful that 
the 2-methyl group of PLP could be involved in catalysis, but 
it is reasonable that replacement of the methyl with a larger 
alkyl group might produce steric problems that would result in 
loss of enzymic activity. 
The involvement of the pyridine nitrogen was tested by 
Fischer et aA. with N-methylpyridoxal phosphate. This deriva­
tive gave no reactivation of apophosphorylase; however, utra-
centrifuge experiments indicated that this derivative did not 
bind to the apoenzyme. A mechanism requiring protonation-
deprotonation of the pyridine nitrogen during catalysis is 
therefore not ruled out by the analogue work. ' 
Kastenschmidt et (1968) have studied the properties of 
apo-b reconstituted with pyridoxal and 5-deoxypyridoxal. Re-
constitution with these analogues, as will be recalled from an 
earlier section, returns the ultracentrifugal properties 
characteristic of dimer phosphorylase b. While the enzyme 
activity is not restored, the allosteric properties observed 
in AMP binding to the holoenzyme are restored. The binding of 
AMP to the 5-deoxypyridoxal reconstituted enzyme showed typical 
homotropic interactions with n = 2 for AMP between 1.0 ^nd 3 
— 5 
X 10 M. These interactions, as discussed earlier, are not 
20 
observed with the apoenzyme. In 5 x 10 ^  M glycylglycine buf­
fer holophosphorylase b exhibits a dissociation constant for 
—4 —2 AMP binding greater than 50 x 10 M; the presence of 2 x 10 
-4 M G-l-P lowers the dissociation constant to 0.8 x 10 M. This 
heterotropic interaction between AMP and G-l-P in glycyglycine 
buffer could also be observed with the 5-deoxypridoxal reconsti­
tuted enzyme. In this instance, the presence of 2 x 10 ^ M 
G-l-P lowers the AMP dissociation constant from greater than 50 
-4 -4 X 10 to 4.6 x 10 M. Combining these results with the obser­
vation that apophosphorylase b binds glycogen as tightly as the 
holoenzyme would indicate that the 5-deoxypyridoxal reconsti­
tuted enzyme is not inactive because it cannot bind substrates 
and activator. However, nonproductive complexes cannot be 
ruled out with the data presented. 
NaBH^ reduced enzyme 
A unique modification of the PLP in phosphorylase can be 
brought about by reduction of the enzyme under appropriate con­
ditions with sodium borohydride (Fischer et al., 1958). The 
species that is reduced is the imine between PLP and an e-amino 
group of a protein lysyl residue. The reduction causes the PLP 
to be fixed on the enzyme irreversibly as a substituted pyri-
doxamine derivative. Direct proof of the structure of the 
reduced species was obtained by extensive chymotryptic digestion 
of the reduced enzyme which gave the dipeptide e-N-pyridoxal-
phosphatelysylphenylalanine (Nolan et , 1964). Normally, 
the reduction does not take place between pH 5 and 
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9.5, but at the extremes of this pH range, a yellow PLP-
enzyme imine is formed that is readily reducible. The PLP is 
not thought to be bound to the enzyme as an imine between pH 5 
and 9.5, but rather, as an imine addition product with some 
side chain nucleophile. The basis for this assignment will be 
thoroughly discussed in a later section of the review. The 
most important aspect of the enzyme is the retention of catalyt­
ic activity. At pH 6.8, 50-60% of the specific activity of the 
native enzyme is retained. The reduced phosphosphorylase is 
therefore unique among PLP enzymes in that it does not require 
an imine linkage between the PLP and the enzyme as a prerequi­
site for catalytic activity. 
The properties of reduced phosphorylase b have been 
reported to be very similar to those of the native enzyme 
(Fischer et a^., 1963; Strausbauch et ^., 1967). The native 
and reduced enzymes have similar sedimentation constants, pH 
dependence of enzyme activity, activation energies, Michaelis 
constants for AMP and G-l-P, urea and heat stabilities, and 
degree of inhibition by phlorizin. The reduced b is converted 
to the a form by phosphorylase kinase and back to the b form 
by phosphorylase phosphatase at essentially the same rates 
found with the native enzyme. Sealock and Graves (1967) found 
the same sigmoidal effect of AMP on the kinetics of reduced b 
as was observed with native b. This has been verified by the 
direct binding experiments of Kastenschmidt et (1968); the 
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heterotropic interactions between G-l-P and AMP characteristic 
of the native enzyme were also observed for the reduced enzyme 
by these workers. 
Spectral Properties of PLP in Phosphorylase 
Absorption spectra 
Phosphorylase b and a exhibit a well defined UV absorbance 
maximum at 333 nm which has essentially constant absorbancy in 
the pH range between 5.0 and 9.5 (Kent, 1959; Kent et al., 
1958). At pH 6.8 and at an enzyme concentration of 10 mg/ml, 
the absorbance at 333 nm is 0.54. A small subsidiary maximum 
is also seen around 415 nm in phosphorylase preparations. This 
shoulder increases with age of the enzyme and the increase 
roughly parallels loss of enzymic activity. Kent has observed 
that the 415 nm absorbance can be as low as 8% of the 333 nm 
absorbance in fresh preparations, and as much as 30% in aged 
preparations. No method of enzyme preparation was found that 
would reduce the 415 nm absorbance below the 8% level. 
If the pH of a solution of phosphorylase is lowered below 
pH 5.0, a new maximum at 415 nm is seen with a concomitant 
decrease at 333 nm, and a reasonably sharp isosbestic at 357 nm. 
The observation of the isosbestic absorbance is consistent with 
the 333 nm species being transformed directly to a new species 
absorbing at 415 nm. At extreme acid pH, the 415 nm species 
faded. This phenomena could be seen in 0.3 N perchloric acid 
where the fading could be correlated with the appearance of 
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295 nm absorbing material (the absorbance maximum for PLP in 
acid solution) in the perchloric acid supernatant. Kent inter­
preted the data to mean that the bound PLP passes through a 
form absorbing at 415 nm before it is removed from the enzyme 
in acid solution. 
A similar phenomenon could be observed at alkaline pH. 
In this instance a species is formed absorbing in the 400 nm 
region which continually shifts its absorbtion to 388 nm, the 
absorbance maximum of free PLP in alkaline solution. A sample 
of enzyme dialyzed at pH 10.8 gave an absorbance maximum at 
408 nm. In accordance with titration data at acid pH, Kent 
felt that the data at alkaline pH indicated that the 333 nm 
species of bound PLP passed through a form absorbing above 400 
nm when the PLP was split from the enzyme. The 333 nm to 415 
nm transformation observed at acid pH is not a process that can 
be assigned a definite pK. Kent observed that with aged enzyme 
the 415 nm species developes at appreciably higher pH values. 
There is good evidence that the 333 nm to 415 nm transformation 
depends strongly on protein conformation. A transient species 
that absorbs at 415 nm was observed by Kent when the enzyme was 
diluted in 7 M urea at 0°. A fairly stable 415 nm species 
could also be generated with various aqueous detergents at 
neutral pH. Ford and Mason (1968) reported that incubation of 
phosphorylase b with various anionic steroids resulted in the 
formation of a species absorbing in the 400 nm region with a 
resulting decrease of the 333 nm species and enzymic activity. 
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Estradiol disulfate formed a species absorbing at 420 nm, and 
dialysis of the enzyme to remove the steroid returned the 
original spectrum and 70% of the enzymic activity. A reversible 
333 nm to 415 nm transformation at neutral pH has also been 
sulfhydryl reagents was made 1.5 M in NaCl and cooled to -5°. 
A slow transformation to a 415 nm absorbing species was ob­
served; subsequent rewarming of the enzyme solution to room 
temperature reversed the spectral change. 
Kent et (1958) postulated the following structures 
for the bound PLP to explain the 333 nm and 415 nm spectral 
forms. 
The 415 nm species was interpreted to be a hydrogen-bonded, 
protonated Shiff base and the 330 nm form was considered to be 
a zwitterionic addition product of some nucleophilic group (X) 
observed by Graves.^ Phosphorylase in the absence of AMP and 
415nm 
H H 
^Graves, Donald J., Ames, Iowa. Data from cold inactiva-
tion studies. Private communication. 1963. 
25 
on the protein with the Schiff base. The 333 nm to 415 nm 
conversion was visualized to be the result of a protein con­
formational change. The schiff base formed would be relatively 
stable or would hydrolyze, depending on the extent of the con­
formational change. 
Kent observed that the yellow, 415 nm absorbing imine 
could be reduced with NaBH^, allowing the PLP to be irrevers­
ibly fixed to the enzyme. This is illustrated in the scheme 
that follows : 
The 333 nm form in the native enzyme maximally present between 
pH 5.0 and 9.0 could not be fixed to the enzyme by NaBH^ 
reduction. There was no appreciable spectral change even in 
the 415 nm region after reduction at neutral pH, It would 
appear, then, that the 415 nm species characteristic of the 
native enzyme is not identical with the 415 nm form in the 
conformationally perturbed enzyme. Incubation of the enzyme 
with NaBH^ at pH 10, where a definite increase in 415 nm 
+ HN NH 
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absorbance is visible, results in 60% fixation of PLP in two 
hours which is consistent with the postulated mechanism of 
alkaline hydrolysis of PLP from the enzyme. As indicated 
earlier, chymotryptic cleavage of reduced phosphorylase a 
yields the dipeptide e-N-pyridoxalphosphatelysylphenylalanine 
(Nolan et al., 1964). Forrey (1963) observed that the in­
soluble core which is obtained by precipitation at pH 4 after 
tryptic attack constitutes only 25-35% of the protein but 
contained 60-70% of the bound PLP. This result intimates that 
the PLP might be bound in a more hydrophobic portion of the 
protein. 
Kent considered the possibility that the PLP in the 
reduced enzyme did not occupy the site at which it was initially 
bound in the native enzyme. Migration of the PLP was checked 
for by adding enzyme, (NH^)and NaBH^ together at 
alkaline pH and then dropping the pH quickly to pH 4.5 with 
acetic acid. Any free aldehyde formed would be reduced to 
pyridoxins phosphate and would show up in the supernatant, and 
in fact, none was found. This experiment did not rule out the 
possibility of transimination, in which the PLP could be trans­
ferred from one e-amino group of lysine to another without 
involving a free aldehyde intermediate. However, such a trans­
formation would have to be quite specific and complete, since 
a good yield of the chymotryptic dipeptide was isolated. 
The reduced enzyme, while having many catalytic properties 
similar to the native enzyme, had spectral properties that were 
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quite distinct from the native enzyme (Kent, 1959). In 
contrast to the native enzyme which shows essentially constant 
absorbance between pH 5 and 9, the reduced enzyme shows a pH 
dependent spectral transition centered around pH 6. Above pH 
6.5, the reduced enzyme shows no well defined peak at 330 nm, 
and at pH 9.0 the absorption for 10 mg/ml of phosphorylase b 
was reported to be only 0.105 at 332 nm, while at pK 4.5 a 
value of 0.78 and a well defined peak was obtained. Kent 
speculated that the spectral change might be the result of a 
change in the pK of the pyridinium nitrogen possibly caused by 
the proximity of some positively charged residue. 
The interpretation of the spectra of reduced and native 
phosphorylase by Kent was based on model compound data available 
at the time. This data indicated that a zwitterionic PLP 
analogue with a saturated carbon at the 4' position would be 
expected to absorb in the 330 nm region (Metzler and Snell, 
1955). Because of the 330 nm to 415 nm conversion, Kent pro­
posed an imine addition product as the most likely species to 
explain the 333 nm absorbance. For instance, the reaction of 
cysteine and cysteinylglycine with PLP results in thiazolidine 
ring formation yielding a stable adduct that absorbs at 330 nm 
(Matsuo, 1957; Buell and Hanson, 1960). More recent model 
compound studies have indicated that there are other species 
that could also explain the 333 nm absorbance in phosphorylase. 
Heinert and Kartell (1963) have shown that a tautomeric imine 
of PLP and PLP analogues can absorb in the 330 nm region. This 
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species is a neutral form that is favored in solvents less 
polar than water such as methanol and dioxane. If such a 
species were present in phosphorylase, the environment around 
the bound PLP would have to favor this neutral species. The 
species under discussion is depicted below. 
An enzyme conformational change could then bring this species 
into contact with a more polar environment which would result 
in the formation of a protonated, dipolar imine absorbing at 
415 nm identical to that discussed earlier. 
An analogous scheme can be proposed to explain the spec­
tral properties of the reduced enzyme. In this case the bound 
PLP can be regarded as a substituted pyridoxamine derivative. 
Matsushima and Martell (1967) have shown that pyridoxamine has 
a form that absorbs at 289 nm in neutrdl methanol solution. 
This species is interpreted to be a neutral, nonpolar form. 
The presence of such a species in the reduced enzyme would 
explain the absence of absorption in the 330 nm region at 
neutral pH. The following structure indicates the species under 
:N 
HO 
OPO3H 
N 
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discussion. 
\ \.\ \ 
NH 
\ 
CH, 
HO 
To explain the appearance of absorption in the 330 nm region 
in the reduced enzyme as the pH is lowered, a conformational 
change would have to be postulated that would expose the bound 
PLP to a more polar environment. The original proposal of 
Kent involved changing the pK of the pyridinivim nitrogen in a 
drastic way. Model compound studies (Metz1er and Snell, 1955) 
would predict a shift of the absorption spectrum to lower 
wavelengths by about 15 nm. The reappearance of 330 nm absorp­
tion would then be a result of protonating the pyridine nitro­
gen to reform the dipolar anion. ' 
There are a number of other protein systems in which bound 
PLP shows a principal absorption maximum at 330-340 nm. An 
equimolar mixture of bovine plasma albumin and PLP forms an 
adduct which absorbs at 332 nm. An imine addition product has 
also been proposed in this system to explain the observed 
absorbancy maximum (Dempsey and Christensen, 1962). Glutamate 
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decarboxylase from E. Coli exhibits a single maximum at 335 nm 
when the pH is 6.5 (Shukuya and Schwert, 1960). Anderson and 
Chang (1965) demonstrated that reaction of this form of the 
enzyme with NaBH^ would not fix the PLP irreversibly to the 
enzyme or destroy the enzymic activity. Reduction of the 
enzyme at a lower pH where a 420 nm absorbing form predominates 
does cause loss of activity and PLP fixation. The y-form of 
supernatant glutamate-asparatate transaminase form pig heart 
exhibits a single maximum at 340 nm which shows no change in 
absorbance between pH 5.4 and 8.5. The enzyme is not affected 
by treatment with NaBH^ or the usual procedures for resolution 
(Martinez-Carrion et s^., 1965). Finally, Soda and Misono 
(1968) have purified an L-lysine-a-ketoglutarate amino trans­
ferase from Achromobacter liquidum. This enzyme has two 
absorption maxima, one at 340 nm and one at 415 nm, and contains 
two moles of PLP for each mole of enzyme. Resolution of the 
enzyme by a common procedure results in an inactive "semiapo-
enzyme" which still has the 340 nm band and one mole of PLP. 
As, in the case of phosphorylase, the 330-340 nm absorbance in 
the PLP systems that have been discussed could be interpreted 
in terms of either an imine adduct with a protein nucleophi,le 
or a tautomeric, neutral PLP imine. A protein environment 
that would stabilize the tautomeric imine might also be 
expected to protect it from reduction with NaBH^. 
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Fluorescence 
PLP enzymes have distinctive fluorescence properties in 
addition to UV absorption properties. By comparing the fluo­
rescence properties of PLP bound to an enzyme to the properties 
of PLP model compounds, information can be obtained about how 
the PLP is bound. The fluorescence spectrum can therefore 
serve as a useful adjunct to the absorption spectrum in inter­
pretive work. Fluorescence also offers the advantages of 
usually requiring lower protein concentrations and being more 
sensitive to the protein environment around the bound chromoph-
ore. The first attempt at observing PLP fluorescence in phos-
phorylase was negative. It was reported that neither native 
nor reduced phosphorylase exhibited any fluorescence due to 
PLP at pH 6.8 (Fischer et al., 1963; Forrey, 1963). However, 
reduced phosphorylase did show PLP fluorescence below pH 6.0. 
Inspection of the data of Forrey (1963) indicates the emission 
maximum for this fluorescence is about 390 nm and the excita-
I 
tion maximum about 330 nm. The observed fluorescence correlates 
well with the appearance of the 330 nm band observed by Kent 
below pH 6.0 in the reduced enzyme. More recent work indicates 
that the PLP in phosphorylase is indeed fluorescent although 
the intensity is low. Shaltiel and Fischer (1967) observed an 
emission maximum at 530 nm and an excitation maximum at 330 nm. 
In good agreement with this data was the report of Ford and 
Mason (1968), who found an emission maximum at 525 nm and an 
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excitation maximum at 340 nm. Thèse workers found that in 
the presence of estradiol disulfate, which mediates a 333 nm 
to 420 nm conversion in the absorption spectrum, the emission 
maximum changed to 510 nm and the excitation maximum shifted 
to 425 nm. 
Other PLP enzymes show a long wavelength fluorescence 
around 500 nm. Glutamate-aspartate transaminase from pig heart 
at acid pH has an excitation maximum at 430 nm and an emission 
maximum at 500 nm (Fasella et , 1961) . Shukuya and Schwert 
(1960) have reported that glutamate decarboxylase has a low 
pH form which emits at 490 nm maximally when 420 nm light is 
used for excitation. In both of these enzymes, the absorption 
data indicates that the PLP is bound as a protonated imine 
which would be expected to absorb in the 420 nm region (Metzler, 
1957; Matsushima and Martell, 1967). The long wavelength 
fluorescence around 500 nm therefore indicates the presence of 
the protonated imine. With phosphorylase such a facile inter­
pretation cannot be made. Although phosphorylase does show 
some absorption around 415 nm in the native enzyme, the 
observed excitation maximum indicates that only the species at 
333 nm contributes appreciably to the observed fluorescence. 
Bridges et al. (1966) have compiled fluorescence data on 
the various ionic species of PLP analogues that are present in 
aqueous solution. In particular, the dipolar ionic species 
that have saturated 4' carbons and show absorption in the 330 nm 
region all have Stokes shifts of 5-6,000 cm The dipolar 
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imine addition product proposed by Kent to explain the 333 nm 
form would be expected to have a similar shift. The experi-
-1 
mentally reported shift of 10-11,000 cm is therefore clearly 
anomalous. Anomalous Stokes shifts have also been observed 
under certain conditions in compounds analogous to PLP and PLP 
imines. These systems will be discussed in some detail in 
order to provide a basis for interpreting phosphorylase fluo­
rescence. An interpretation will be presented here since none 
has yet appeared in the literature. 
Weller (1955, 1956) has studied the fluorescence of 
salicylic acid and its derivatives. Salicylic acid exhibits 
fluorescence in methanol with a long Stokes shift (10,900 cm~^). 
Weller demonstrated that the ortho hydroxy1 group of salicylic 
acid was necessary for this long Stokes shift. Replacement of 
the hydroxy1 hydrogen with a methyl group to give 0-methpxy 
benzoic acid caused the Stokes shift to become normal (5,900 
cm Weller interpreted the long Stokes shift to be the result 
of a proton transfer in the excited state. The process for 
salicylic acid is shown in the following scheme. 
COOH! COOH 
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The hydrogen from the hydroxy1 group is transferred to the 
protonated carboxyl group in the excited state to form a 
positively charged, doubly protonated carboxyl group. The 
methyl ester of salicylic acid behaved the same as salicylic 
acid, giving a Stokes shift of 10,500 cm The 0-methoxy 
benzoic acid methyl ester exhibited a normal Stokes shift of 
4,800 cm Further support for the excited state, intra­
molecular proton transfer was obtained from fluorescence 
studies of salicylic acid in 6 N potassium hydroxide and con­
centrated sulfuric acid. The experimental conditions should 
prevent a proton transfer in the excited state, and the observed 
Stokes shifts of 5,600 cm ^ in potassium hydroxide, and 5,700 
cm ^ in sulfuric acid are in agreement with Weller's interpre­
tation. The formation of the zwitterionic excited state 
results from ionization constant changes in going from the 
ground state to the excited state. Weller estimates the acidity 
I 
of the aromatic OH is 5 to 8 pH units higher in the excited 
state, and the acidity of the aromatic COgHg* is 6 to 8 pH 
units lower in the excited state; these conditions would com­
bine to make the zwitterionic excited state the predominant 
species. 
Cohen and Schmidt (1962) have studied the spectral pro­
perties of the thermochromic anil 5'-chlorosalicylidine. This 
compound in the crystalline state undergoes a tautomerization 
when warmed from -153° to -49° with a resulting shift of an 
absorption band to longer wavelengths. The process is inter­
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preted as a benzoid to quinoid tautomerization and is illus­
trated in the following scheme. 
Cohen and Schmidt have observed a large Stokes shift in fluo­
rescence for the species at -153° and have indicated that this 
fluorescence emission band approximately mirrors the absorption 
band observed at -49*. An explanation similar to that Weller 
used for the salicylic acid system was used to explain the 
observed long Stokes shift i.e., excitation of the benzoid 
ground state present at -153° leads to an intermolecular proton 
transfer in the excited state yielding an excited species which 
gives the long wavelength fluorescence upon emission. 
In analogy with the two systems discussed, we can inter­
pret the long wavelength fluorescence that is derived from the 
333 nm absorbing species in phosphorylase, if we first assume 
that the 333 nm form is a tautomeric imine. This tautomeric 
imine could also undergo intramolecular proton transfer in the 
excited state to give an excited species fluorescing at 525 nm. 
This is illustrated in the following scheme. 
-153° -49° 
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Unfortunately, model PLP imines which exhibit a 330 nm band 
have not as yet been tested for the ability to show a long 
Stokes shift when excited in the 330 nm band. At this time it 
can only be said that the fluorescence characteristics of phos-
phorylase would seem to be best explained if we postulate the 
tautomeric imine as the species absorbing at 333 nm. 
Of the four PLP-proteins previously discussed that also 
have absorption bands at 333 nm, fluorescence data is available 
only on two; the adduct of PLP and bovine plasma albumin and 
the 340 nm form of glutamate decarboxylase. Fasella et al. 
(1961) reported that the adduct of PLP and bovine plasma 
albumin exhibits an excitation maximum at 330 nm and an emission 
maximum at 390 nm. Shukuya and Schwert (1960) indicated that 
glutamate decarboxylase in the 340 nm form emits at 380 nm when 
excited with 335 nm light. Both systems have the type of 
fluorescence that would be expected from dipolar imine addition 
products. Phosphorylase is therefore unique in its fluorescence 
at this time. 
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Difference spectra 
Because of the lack of any detailed structural work on 
phosphorylase involving sequence analysis, active site-directed 
reagents, and ultimately x-ray crystallography, it cannot now 
be decided whether the PLP in phosphorylase is at the catalytic 
site or at a site distinct from it. However, data has been 
presented that show a spectral change can occur in the absorp­
tion band of the bound PLP when phosphorylase b binds its 
substrates. The spectral change was experimentally observed 
as a small difference spectrum with a dual beam spectrophoto­
meter that had a concentrated phosphorylase b solution in the 
reference beam, and at equal concentration in the sample beam, 
a b solution that contained AMP and substrate (Bresler et al., 
1966, 1968; Bresler and Firsov, 1968). The substrate could 
be either phosphate or G-l-P but not glycogen. The difference 
spectrum was observed only with AMP and anionic substrate 
together and not with either alone. The data of Bresler et al. 
(1966) show the difference spectrum with a maximum at about 
360 nm, a crossover at about 340-345 nm and a minimum at 320 nm 
with G-l-P as the substrate. With phosphate as the substrate, 
the minimum appeared to be nearer 330 nm. In a later paper 
(Bresler and Firsov, 1968) somewhat different data were 
obtained: the difference spectrum with G-l-P (no data was 
reported for phosphate) was said to have a maximum near 360 nm, 
a crossover near 333 nm, and a minimum about 310 nm. Buc and 
Buc (1968) have used the difference spectrum to follow the 
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binding of phosphate to phosphorylase in the presence and 
absence of AMP. It was found that in the absence of AMP, the 
difference spectrum appeared only at high phosphate concentra­
tion. The binding curves and constants obtained from them were 
consistent with the allosteric model proposed by these authors. 
The difference spectrum observed by Buc and Buc in the presence 
of phosphate had a maximum at 365 nm, a crossover at 345 nm and 
a minimum at 320 nm. Bresler et (1966) observed that ATP 
and glucose which inhibit the rate of enzymic catalysis in an 
allosteric manner, also cause a decrease in the difference 
spectrum. The observed decrease in the intensity of the spec­
trum would presumably reflect a decreased capacity for phos­
phate and G-l-P to bind to the enzyme in the presence of these 
allosteric inhibitors. 
The difference spectrum itself could originate in two main 
ways. In one model, the enzyme saturated with AMP and anionic 
substrate could have a PLP absorption band that is slightly red 
shifted with respect to the free enzyme. The alternative model 
would require that a small amount of a new species in equilib­
rium with the normal 333 nm species be formed when the enzyme 
bound AMP and substrate. The first model predicts that the 
crossover in the difference spectrum will occur very near 333 
nm, while the second model would assign the 360 nm maximum in 
the difference spectrum to a new species, and would predict 
that the crossover would not be at 330 nm. Unfortunately, 
there are discrepancies in the reported results about where 
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the crossover in the difference spectrum is located. Until 
further experimental results are available, a profitable 
discussion cannot be made about the origin of the difference 
spectrum. Bresler and Firsov (1968) did indicate that the 
magnitude of the difference spectrum was a linear function of 
enzyme concentration (5-20 mg/ml) and that the magnitude of 
the spectrum did not change between 20° and 40°. The results 
were interpreted to mean that dimerization of phosphorylase b 
was not responsible for the difference spectrum. 
It should be made clear that the spectral change in the 
bound PLP does not necessarily mean that PLP in phosphorylase 
is or is not at the catalytic site. The binding of AMP and 
substrate to phosphorylase b could cause a conformational 
change in the enzyme that might produce changes in environment 
at the PLP site, even if it were far removed from the catalytic 
site. In fact an enzyme species might be involved that has an 
altered PLP spectrum, but which might not even be on the main 
catalytic sequence; all that is required is that the species 
I 
be in equilibrium with an active complex. 
Circular dichroism 
The bound PLP in phosphorylase exhibits optical activity 
in its absorption band. This has been found to be the case for 
all PLP enzymes that have been investigated for optical activ­
ity. The circular dichroism band in phosphorylase b appears as 
a symmetrical band centered at 333 nm where the absorption 
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maximum also occurs (Torchinsky et , 1965, 1968; Johnson 
and Graves, 1966). The 415 nm absorbing form produced at acid 
pH was observed to be optically inactive, and it was further 
observed by Johnson and Graves that the 415 nm form produced 
by detergent was also optically inactive. Reduced phosphorylase 
was found to have lost at least 60%'of the CD characteristic of 
the native enzyme (Johnson and Graves). This observation is 
consistent with the loss of absorption at 330 nm observed by 
Kent (1959) in the reduced enzyme. 
The presence of PLP CD in phosphorylase provided another 
spectral probe into the protein environment around the bound 
cofactor. Both Torchinsky et al. (1968) and Johnson and Graves 
(1966), have reported that neither G-l-P, AMP or an equilibrium 
system containing glycogen perturbs the observed CD of the 
enzyme. As in the case of absorption spectroscopy, however, 
small absolute changes would have gone undetected. In contrast 
to the CD results, changes in the optical rotatory dispersion 
of the enzyme has been reported when AMP is present (Hedrick, 
1966) . These changes were reflected in the parameters of a 
Drude plot that was obtained between 400 nm and 600 nm. 
Because of the CD results, it is doubtful that the observations 
of Hedrick would indicate a change in PLP optical activity. It 
is more probable that the environments of other protein chromo-
phores were affected by AMP binding, giving rise to the optical 
activity change. 
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The state of enzyme aggregation also had little effect on 
the observed CD. Phosphorylase b (a dimer) and a (a tetramer) 
gave the same CD within experimental error (Johnson and Graves). 
Dissociation of phosphorylase b into monomers could be induced 
at alkaline pH. Under conditions where 50-90% of the b existed 
in the monomeric form, very little change in CD was found 
(Torchinsky et al., 1968). This was interpreted to mean that 
PLP was not involved in contact interactions between monomers. 
Another means of monomerization involves the use of the sulf-
hydrl reagent PMB, whose action can be reversed by addition of 
mercaptan to the enzyme. In this instance, CD changes were 
observed. Torchinsky et (1968) report about a 40% loss of 
CD, and Johnson et (1968) report a reversible loss of 15-
20% of the CD. The CD results would seem to indicate that 
monomerization by PMB results in a larger conformational change 
than monomerization by alkaline pH. 
Direct comparison of the CD results discussed in this 
section is most easily accomplished by use of the anisotropy 
factor of Kuhn (1958). This factor is equal to Ae/e, in which 
e is the usual molar absorption coefficient, and Ae is the 
observed CD expressed as the difference between the molar 
absorption coefficients of left and right circularly polarized 
light. The most useful aspect of the factor is its concentra­
tion independence. For instance, it allows comparison between 
PLP enzymes where the purity of the enzyme is uncertain. 
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Obviously for the comparison to be valid, the absorption band 
for the bound PLP must be far enough removed from the protein 
absorption band. The value of Ae/e at 333 nm in phosphorylase 
_3 b at neutral pH has been reported to be 1.1 x 10 by Johnson 
and Graves (1966), and 0.86 x 10 ^ by Torchinsky et (1968). 
The two results agree well considering the possible errors in 
machine calibration and variability of enzyme preparations. 
Values of Ae/e at 333 nm are also available for lobster muscle 
b and potato phosphorylase. Johnson and Graves report a value 
of 0.92 X 10 ^ for the lobster enzyme, and Kamogawa et al. 
_3 (1968) give a value of 0.89 x 10 for the potato enzyme. This 
similarity of values for the different phosphorylases indicates 
a similarity in the binding sites for PLP. 
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EXPERIMENTAL 
Materials 
Pyridoxal phosphate analogues 
The analogues of PLP used in this work were kind gifts 
from the laboratory of Dr. David E. Metzler at Iowa State 
University, Ames. Some of the analogues were synthesized in 
Dr. Metzler's laboratory and some were synthesized in other 
laboratories. Data on the origin of each compound can be 
found in the Ph.D. thesis of Furbish (1969). Pyridoxal 
Phosphate itself was obtained from the Sigma Chemical Company. 
The names and structures of the analogues used in this work 
that were not described previously in Table 1 can be found in 
Figure 1. 
Chemicals 
All chemicals were obtained from commercial sources and 
were reagent grade. Imidazole was obtained from the Sigma 
Chemical Company as an off-white material. It was recrystal-
lized from ethyl acetate and dried under reduced pressure over­
night in a vacuum desiccator. 
Native phosphorylase b 
The enzyme was prepared from frozen rabbit muscle essen­
tially as described by Fischer and Krebs (1962). g-Mercapto-
ethanol replaced L-cysteine»HCL in the preparation. The enzyme 
44 
ÇHO 
CH R O 
HX I - IV 
I R = -CHgCOgH 
II R = -PO3H2 
III R = -OPfOCHgCHgCNiOgH 
IV R = -OPfCH^iOgH 
O H20P03H2 
Figure 1. Names and structures of analogues 
I Carboxymethyl-deoxypyridoxal 
II Deoxypyridoxalyl phosphonic acid 
III Pyridoxal phosphate cyanoethyl ester 
IV Pyridoxal methylphosphonic acid 
V N-Oxide pyridoxal phosphate 
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was routinely recrystallized at least three times at 0° from a 
pH 6.8 buffer consisting of 0.05 M glycero-P, 0.05 M g-ME, 
0.001 M AMP and 0.01 M Mg^^. The last recrystallization was 
2+ 
usually done without added AMP and Mg . Residual AMP was 
removed by treating the enzyme with acid washed Norit (char­
coal) . A ratio of absorbancies (A-f. ) of 0.54-0.56 iSou nm zou nm 
was considered a satisfactory indication of AMP removal. 
Reduced phosphorylase b 
The method for preparation of reduced enzyme was essen­
tially that of Graves et (1965) . A typical reduction 
involved the following steps. The third crystals of the native 
b obtained from 2 lbs. of frozen rabbit muscle were dissolved 
in 0.1 M glycero-P at pH 6.8 to give 30 ml of enzyme solution 
(20-30 mg/ml), and residual AMP was removed. Enough solid 
NaCl was added to the enzyme solution to give a final concen­
tration of 1.5 M, and the solution was subsequently cooled in 
a glass-stoppered flask to -5° in a refrigerated bath of water-
ethylene glycol. After the enzyme solution had turned a 
bright yellow, small crystals of NaBH^ (1-3 mg) were added with 
gentle stirring. This immediately bleached the yellow color 
which slowly returned after about 15 min.; at this time another 
addition of NaBH^ was made. Usually a total of 3-4 additions 
were required at 15 min. intervals to give a colorless final 
solution. After reaction was complete 70 ml of 0.05 M glycero-
P, 0.05 M 3-ME at pH 6.8;were added; this was followed by 
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100 ml of neutral, saturated (NH^igSO^ to precipitate the 
enzyme. The precipitate was centrifuged in the cold, dissolved 
in the glycero-P, g-ME buffer, and dialyzed against this 
buffer overnight. The dialyzed, reduced enzyme was crystal-
2+ lized in the usual manner (AMP + Mg ). Crystallization was 
slower than with native enzyme and gave crystals that appeared 
much whiter. The reduced enzyme was stored as a crystalline 
suspension at 0°. 
Apophosphorylase b 
Apophosphorylase b was prepared according to the procedure 
of Shaltiel et (1966). Usually 250 mg of native b were 
used in the procedure. For desalting after resolution, a 
1.5 cm X 22 cm Sephadex G-25 column was used (8.8 g of G-25); 
the apoenzyme came off the column at 15-16 mg/ml. Apoenzyme 
was usually stored in pH 6.0 buffer at 0®. 
Methods 
Spectrophotometric measurements 
UV spectra were recorded in 1 cm silica, semimicro cells 
(1.5 ml) on a Gary 15 recording spectrophotometer. CD spectra 
were taken in the same cells on a modified Jouan dichrograph 
that has been previously described (Johnson and Graves, 1966; 
Johnson et a^., 1968). Sensitivity of the instrument was 1-2 
X 10 ^ AA as determined from the noise on the trace with the 
experimental conditions employed. The CD spectra that are 
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presented in this thesis were obtained by drawing smooth 
curves though the traces and baseline, and then replotting the 
data every 5 nm and drawing a smooth curve through the points. 
Protein concentration 
Protein concentration was determined spectrophotomet-
1% 
rically using an absorbancy index of Agyg ^  of 11.9 for phos-
phorylase b (Appleman et a2., 1963). The same index was used 
in calculating concentrations of apo-b and reduced b. To 
determine concentration, AMP was removed as previously described 
and the concentrated enzyme diluted in 0.1 M glyceo-P buffer at 
pH 6.8. 
Molecular weight 
A molecular weight of 185,000 for dimer phosphorylase b 
(Seery et , 1967) was used when it was necessary to calcu­
late enzyme molarity. 
Assay of phosphorylase 
Phosphorylase was assayed in the direction of glycogen 
synthesis by the method of Illingworth and Cori (1953). 
Initial rates of reaction were determined by stopping the 
reaction at intervals and measuring the phosphate released from 
G-l-P. A fixed time assay with the substrate concentrations 
of Hedrick and Fischer (1965) was used in some of the analogue 
work. ! 
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RESULTS AND DISCUSSION 
Native Enzyme 
Spectral properties 
Figure 2 illustrates the type of absorption and CD data 
characteristic of native phosphorylase b. This data is pre­
sented here to allow comparison with data that will be pre­
sented in later sections on reduced b, and apo-b reconstituted 
with analogues. The bound PLP exhibits a principle absorption 
maximum at 333 nm, and for this particular preparation an 
1% Ag?? ^ of 0.55 was observed. There is also a small shoulder j j j nm 
visible in the absorbtion spectrum near 420 nm. The absorption 
in this region is only 0.1 of that of the 333 nm absorbancy 
maximum. 
The CD spectrum shown at the right of the UV spectrum in 
Figure 2 was taken on the same sample used for the absorption 
spectrum. The CD spectrum is also centered at 333 nm. A 
AA/A value calculated at 333 nm equals 1.3 x 10 at 360 nm 
the AA/A value equals 0.92 x 10 ^ . The half-widths for the CD 
and UV data on the long wavelength side of the maxima are 
approximately equal with values of 29 nm for the absorption 
data and 25-27 nm for the CD data. 
Figure 3 shows CD data obtained at very high enzyme con­
centration in the long wavelength region (400-500 nm) . The 
CD goes off scale as the 333 nm maximum is approached. The 
data indicate that the bound PLP species responsible for the 
Figure 2. Absorbtion and CD spectra of phosphorylase b 
Phosphorylase b, 16.6 mg/ml, in 0.02 M glycero-P, 0.015 M L-cysteine at 
pH 6.8. Noise level in the CD baseline was +2 x 10~5 AA. 
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Figure 3. CD of phosphorylase b in the long wavelength region 
Phosphorylase b, 46.2 mg/ml in 0.05 M glycero-P, pH 6.8. Noise level in 
the CD baseline was +3 x 10"^ AA. 
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absorption shoulder at 420 nm is also optically active. A 
value of AA/A of 1.7 x 10 ^ was obtained for this band at 
425 nm. The presence of the enzyme substrate phosphate (.01 M) 
and the activator AMP (.001 M) had no effect on the intensity 
of this CD band. This is in agreement with data obtained 
previously by Johnson and Graves (1966) and Torchinsky et al. 
(1968) where it was shown that AMP and substrates did not 
perturb the 333 nm CD band. 
The presence of a CD band for the 420 nm species indicates 
that it is bound in an asymmetric environment. The random 
association of a small excess of PLP with the many e-amino side 
chains of lysine that are available in phosphorylase to form 
an imine absorbing at 420 nm would not be expected to produce 
observable optical activity. The argument against excess PLP, 
randomly bound, is strengthened by the new molecular weight of 
Seery et al. (1967) for phosphorylase b which, combined with 
the observation of Kent (1959) of 2.5 moles of PLP for each 
250,000 g of enzyme, would indicate only a stoichiometric 
amount of PLP is bound to the enzyme. Moreover, Johnson et al. 
(1968) have indicated thjat loss of CD caused by resolution of 
phosphorylase b with 0.1 M NHgOH in an imidazole-citrate buffer 
occurs at about the same rate at 333 nm and at 420 nm. Random­
ly bound PLP imines would be expected to be immediately removed 
by 0.1 M NHgOH even without the deforming buffer present. 
Finally, Kent (1959) has reported that incubation of phos­
phorylase b with NaBH^ at neutral pH caused no change in 
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absorbance at 420 nm. The species absorbing at 333 nm and near 
420 nm at neutral pH would therefore seem to be bound to the 
enzyme in a similar fashion, and, in fact, could represent 
PLP species bound at the same enzyme site. There is as yet no 
data that would unequivocally demonstrate that the two PLP 
species are in direct equilibrium with each other. 
Reduced Enzyme 
Spectral properties 
Figure 4 shows the CD of a reduced b preparation at pH 
6.75 and pH 4.6. At pH 6.75, the absorbance at 332 nm was 
0.190 while at pH 4.6, the absorbance at 332 nm was 0.715. 
The appearance of a CD band at low pH therefore coincides with 
the appearance of an absorption band in the reduced enzyme. 
The CD seen in this particular preparation at pH 6.75 is 
undoubtably due to incomplete reduction. In well reduced 
1% preparations, values of ^ ^32 nm 6.8) of 0.076 have been 
1% 
obtained; this is to be contrasted with the value of A??-332 nm 
of 0.210 shown by this particular preparation. Using the 
value of AA/A at 333 nm calculated earlier for the native 
enzyme, it can be estimated from the CD results that the pre­
paration of Figure 4 was about 83% reduced. The CD band at 
pH 4.6 shows a AA/A of 0.7 x 10 ^  at 332 nm. In terms of 
1 % 
absolute CD values, AA^^g ^ for the reduced enzyme at pH 4.6 
is about 55 X 10 whereas native b at pH 6.8 gives a AA^^g ^  
of 72 X  l O ' S .  
Figure 4. CD of reduced b at pH 4.6 and pH 6.75 
The top curve is reduced b (8.9 mg/ml) in 0.05 M 
potassium acetate pH 4.6. The bottom curve is 
reduced b (8.9 mg/ml) in 0.05 M glycero-P, pH 6.75. 
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Because of the intense protein band centered at 280 nm, 
it is difficult to detect where the PLP in the reduced enzyme 
is absorbing at pH 6.8. Kent (1959) speculated that the pK 
of the pyridinium nitrogen in the subsituted pyridoxamine 
phosphate residue of the reduced enzyme was drastically lowered 
by the proximity of a positively charged residue. From model 
compound studies (Metzler and Snell, 1955) it can be estimated 
that the monoanion should absorb about 15 nm lower than the 
dipolar form. The appearance of an absorption band at 332 nm 
in the reduced enzyme at low pH would predict that the high pH 
form proposed by Kent should absorb about 317 nm. No absorp­
tion peak or shoulder can be observed above 300 nm in the 
reduced enzyme at neutral pH. The CD results of Figure 4 also 
indicate that a new CD band near 317 nm is not formed. How­
ever, a new band above 300 nm might be formed that is optically 
inactive or shows little optical activity, but absorption data 
appears to already have eliminated this possibility. Thus both 
CD and absorption results would appear to place the hidden PMP 
band below 300 nm. 
Since a substituted PMP derivative in contact with an 
aqueous environment at neutral pH would be expected to absorb 
near 330 nm from model compound studies, it should be possible 
to:generate a 330 nm form from the hidden PMP band at neutral 
pH by deforming the enzyme. Figure 5 shows such an experiment: 
the lower curve shows reduced enzyme at pH 6.8, and the upper 
Figure 5. Spectrum of reduced b in the presence of guanidine• 
HCl 
The bottom curve is reduced b (9.25 mg/ml) in 
0.05 M glycero-P at pH 6.8. The top curve is 
reduced b (9.25 mg/ml) in 4.25 M guanidine•HCl, 
0.025 M glycero-P at pH 6.8. 
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curve shows the reduced enzyme at the same concentration and 
pH, but in the presence of 4.25 M guanidine•HCl. The absorp­
tion maximum appears at 330 nm and exhibits a value of 
1% 
A330 ^  of 0.76. Sodium dodecyl sulfate (0.3%) in an experi­
ment similar to the one in Figure 5 also deformed the enzyme, 
and resulted in a band near 330 nm. In this case the maximum 
1% 
was at 327 nm and gave a value of ^ ^21 nm 0.75. In good 
preparations of reduced enzyme, the 332 nm band formed at pH 
4.6 gave an nm value of 0.77; Kent (1959) reported a 
similar value of 0.78. 
An attempt to find the hidden band was made by difference 
spectroscopy. A solution containing reduced b in the 330 nm 
band form was placed in the sample beam of the Gary 15, and 
in the reference beam a solution was placed containing reduced 
b, at equal concentration, in the hidden band form. The 
reference solution simply contained reduced b at neutral pH, 
and the sample solution had either reduced b at neutral pH in 
the presence of SDS (0.3%), or reduced b at pH 5.0. The 
results of these experiments can be seen in Figure 6. Since 
reduced b with the hidden band is in the reference beam, it 
can only show up as a negative contribution to the difference 
spectrum. The first band that will be observed as X decreases 
should be a positive 330 nm band. In Figure 6 this is what is 
observed in both the SDS and pH 5.0 experiments. The absorb-
aqce at 330 nzn in the SDS experiment is .055 and in the pH 5.0 
Figure 6. Difference spectra of reduced b 
Top curve. Sample cell contains reduced b (0.80 mg/ml) in 0.1 M sodium 
acetate at pH 5.0. Reference cell contains reduced b (0.80 mg/ml) in 
0.1 M glycero-P at pH 7.0. Bottom curve. Sample cell contains reduced 
b (0.72 mg/ml) in 0.05 M glycero-P and 0.3% SDS at pH 6.8. Reference 
cell contains reduced b (0.72 mg/ml) in 0.05 M glycero-P at pH 6.8. 
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experiment is .056; these values agree to within 2% of the 
expected absorbance calculated from dilution factors in each 
case. The absorbance curve crosses the zero line at 302 nm 
in the SDS experiment and at 300 nm in the pH 5.0 experiment. 
The SDS experiment shows two negative maxima at 287 nm and 
293 nm; similar negative maxima are observed in the pH 5.0 
experiment, but are more diminished, and in this case are 
located at 285 nm and 293 nm. These negative maxima are 
probably the result of enzyme conformational changes that 
expose tyrosine and tryptophan residues resulting in a typical 
dénaturation blue shift. A positive maximum is observed near 
254 nm in the SDS experiment and at 257 nm in the pH 5.0 
experiment. 
If we assume that the enzyme is not too greatly perturbed 
by the conditions used to generate the 330 nm band, the cross­
over point in the difference spectrum would be determined by 
the isosbestic point between the hidden band and the 330 nm 
band. Since the crossover in both cases is near 300 nm, this 
would indicate that the maximum of the hidden band must be 
located below 300 nm. Because of the observed perturbation of 
enzyme aromatic residues, the negative contribution of the 
hidden band might be covered up, and it cannot be said with 
certainty where this band is located. 
In the case of the pH 5 experiment, it seems logical to 
assign the 257 nm positive band to the dipolar substituted PMP 
64 
residue. With the parent compound pyridoxamine, there is a 
3 band at 326 nm (e = 7.9 x 10 ), and a band at 252 nm (e = 4.5 
3 X 10 ) in neutral, aqueous solution (Metzler and Snell, 1955). 
Heinert and Martell (1963) have shown that the electronic 
absorption spectra of vitamin Bg analogues are always charac­
terized by two absorption bands designated by them as ir^ and 
^2 bands. If we assume that the ratio of extinction coeffi­
cients of the iT^ and bands present in reduced b at pH 5.0 
is equal to the ratio exhibited by the same bands in the 
parent compound pyridoxamine, we can calculate that an absorb-
ance of .032 should be associated with the band near 260 nm. 
The observed absorbance at 257 nm in the pH 5.0 experiment of 
Figure 6 is .037. The SDS experiment shows a very large 
absorbance near 260 nm, and it must be assumed that the sub­
stituted PMP residue in the reduced enzyme is not responsible 
for more than a fraction of this absorbance. 
The only likely species from model compound studies that 
could be assigned to the hidden band is the neutral tautomer 
I 
of the dipolar PMP species. Matsushima and Martell (1967) 
have shown that pyridoxamine in slightly acidic methanol shows 
bands at 287 nm, 333 nm, 260 nm, and 220 nm. The bands at 
333 nm and 260 nm have been assigned as the and ^2 bands of 
dipolar pyridoxamine; the bands at 287 nm and 220 nm have been 
assigned as the and iTg band of the neutral pyridoxamine 
tautomer. The pH 5.0 difference spectrum in Figure 6 is 
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clearly consistent with the hidden band being near 290 nm. 
The 220 nm iTg band is outside the range of the spectrum. 
Because of the observed CD at pH 4.6 in the reduced 
enzyme, a large conformational change around the PLP probably 
has not taken place at pH 5.0. A larger conformational change 
probably takes place when SDS is added to the reduced enzyme. 
It will be recalled that Johnson and Graves (1966) showed that 
incubation of native enzyme with SDS gave a 420 nm imine that 
was optically inactive. The presence of larger aromatic 
residue contributions in the SDS difference spectrum of Figure 
6 would also implicate a larger conformational change taking 
place. 
The effect of substrates and activator on reduced phos-
phorylase b in the hidden band form were tested in order to 
see if they might affect a conversion to the spectral form 
absorbing at 330 nm. At pH 7.5, AMP (1.3 x 10 ^ M) and phos­
phate (.036 M) had no effect on the spectrum of the reduced 
enzyme, and at pH 6.8 the presence of an equilibrium system 
with initial concentrations of 0.1 M phosphate, .001 M AMP and 
.04% glycogen produced some turbidity but no appearance of the 
330 nm band. The results indicate that when reduced enzyme is 
substituted PMP must remain in the hidden band form; the pos­
sibility that a very small fraction of the hidden band is 
converted to the 330 nm species is not ruled out by these 
results. 
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Figure 7 indicates that there are conditions under which 
AMP will affect the spectrum of the reduced enzyme. At pH 
6.0, the reduced enzyme at 330 nm exhibits about 55% of the 
maximal absorbance,reached at pH 4.6. Addition of .01 M AMP 
to the reduced enzyme at pH 6.0 causes a 59% reduction in 
intensity of the 330 nm band. Reduced enzyme at pH 6.0 in the 
presence of both .01 M AMP and .02 M phosphate did not show 
any greater diminution of the spectrum than AMP produced by 
itself. ATP (7.5 X 10 ^ M) also caused the decrease in the 
pH 6.0 spectrum of reduced enzyme. The spectrum of the reduced 
enzyme at pH 6.8 is also shown in Figure 7. It is apparent 
that AMP will not cause complete reversion to the hidden band 
form. 
The experiment shown in Figure 7 obviously requires a 
more complicated interpretation than a simple protonation of 
the pyridine nitrogen which was earlier postulated by Kent 
(1959) to explain the hidden band to 330 nm conversion. A 
more likely interpretation is that the hidden band form and 
the 330 nm form of reduced b represent different protein con­
formations. To explain the data, AMP would bind more tightly 
to the conformation represented by the hidden band form. The 
inability of saturating AMP to completely reverse the spectrum 
would indicate that the 330 nm form of the enzyme also has 
some capacity to bind AMP. The idea of an enzyme conformational 
change is also more compatable with the previous assignment of 
Figure 7. Effect of AMP on the spectrum of reduced b 
The pH 6.0 curve is reduced b (8.0 mg/ml) in 0.05 M 
glycero-P and 0.05 M g-ME at pH 6.0. The (pH 6.0 
+ AMP) curve is reduced b (8.0 mg/ml) in 0.05 M 
glycero-P and 0.05 M g-ME at pH 6.0 with 0.01 M 
AMP present. The pH 6.8 curve is reduced b (7.8 
mg/ml) in 0.05 M glycero-P, 0.05 M B-ME at pH 6.8. 
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the substituted PMP species responsible for the hidden band. 
The neutral, nonpolar PMP residue characteristic of the 
reduced enzyme at neutral pH would be brought into a more 
polar environment by a conformational change as the pH was 
lowered, resulting in the dipolar 330 nm form. 
Catalytic properties 
Figure 8 shows the pH profiles of the enzymatic activity 
of native and reduced phosphorylase b measured under the same 
conditions. The most obvious difference between reduced b 
and native b is seen at pH 5.4: here, native enzyme has 41% 
of the activity observed at its pH optimum while the reduced 
enzyme has fallen to 0%. If the pH optimum curves had been 
identical, then the ratio of reduced b activity to native b 
activity at all pH values would have been invariant. This is 
not the case; it can be seen that the activity ratio decreases 
smoothly in going from high pH to low pH. The ratios that are 
actually observed at various pH values are given as follows: 
pH 7.8 (.79), pH 7.4 (.72), pH 7.0 (.67), pH 6.4 (.61), and 
pH 6.0 (.57). The results clearly show a skewness in the 
reduced b pH profile. 
The results of Figure 8 give further support to the idea 
that a conformational change is taking place in the reduced en­
zyme as the pH is lowered that is not found in the native enzyme. 
The results reported here are in contradiction to the studies 
reported by Fischer et al. (1963) in which it was indicated 
Figure 8. Effect of pli on the enzymic activity of native and reduced b 
Native and reduced b were diluted in 0.04 M glycero-P, 0.04 M 3-ME at the 
indicated pH values, and assayed using the substrate of Illingworth and 
Cori (1953) which also had been adjusted to the correct pH. Initial 
rates of phosphate release were determined. 
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that reduced and native enzyme have essentially identical pH-
dependence activity curves. Fischer et (1963) and Straus-
bauch et al. (1967) have stressed the similarities between 
native and reduced enzyme. The results shown in Figures 4, 5, 
6, 7, and 8 stress the differences between native and reduced 
enzyme. 
Analogue Reconsituted Enzymes 
Spectral properties 
Figure 9 shows the CD spectra that were obtained when 
apo-b was reconstituted with pyridoxal, deoxypyridoxal, and 
carboxymethyl-deoxypyridoxal (I). In these experiments the 
apoenzyme was incubated with an excess of the analogues, and 
then dialyzed in the cold to remove free analogue. The 
resulting UV spectra of the dialyzed enzymes indicated that 
the analogues were not bound in equivalent amounts. If the 
absorption in the 330 nm region is taken as an index of 
binding, then the order of binding was CMDPL > DPL > PL. The 
CD spectra of Figure 9 are also in this order. The CMDPL 
1% 
enzyme gave a peak at 333 nm with an observed ^ of 0.55; 
1% the DPL enzyme had a peak at 330 nm with an nm 0.41; 
th$ PL enzyme showed no peak and only a weak shoulder near 320 
1% 
nm with an A^on of 0.36. These absorbancès should all be izo nm ' 
taken to be somewhat high, because some turbidity was notice­
able in all the samples. 
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Metzler and Snell (1955) have indicated that DPL has 
absorption characteristics almost identical to PLP. With this 
observation in mind, it was assumed that absorbances at the 
peak positions in the analogue enzymes above that observed in 
the apoenzyme alone would be the most useful index of binding. 
Using this criterion, the ratio of - A^^^)/ {A^,j^pj. - A^^^) 
was found to be 0.57 while the ratio of ^A^p^/^A^^p^ at the CD 
peak positions in Figure 9 was found to be 0.56. The PL enzyme 
showed only 14% of the CD exhibited by the CMDPL enzyme and 
because of its absorption characteristics, it is difficult to 
estimate the amount of PL bound. In another experiment under 
the same conditions used in Figure 9 apo-b was reconstituted 
with CMDPL and PLP. The ratios of the corrected absorbances 
at 333 nm, " ^apo^/^^PLP " to be 0.75; 
^^CMDPL^^^PLP CD measurements at 333 nm was found to be 
0.82. 
The results would appear to indicate that the PLP, CMDPL, 
and DPL enzymes will give very nearly the same CD spectra when 
compared with equivalent amounts of analogue bound. This 
would imply that all these analogues bind at the same site in 
nearly the same way. Other workers have presented data that 
would support this conclusion. Illingworth et a^. (1958) and 
Fischer et al. (1968) have shown that reconstitution of apo-b 
with DPL results in an inactive enzyme that resembles dimer 
native b in its ultracentrifugal properties and not apo-b. 
Also, Kastenschmidt et al. (1968) have shown that reconstitution 
Figure 9. CD of PL, DPL and CMDPL reconstituted b 
Apo-b (14.9 mg/ml) in 0.05 M glycero-P, 0.05 M 3-ME at pH 6.0 was reacted 
2 hr. at 30° with a 3 fold molar excess of analogue over PLP binding 
sites. Enzyme solutions were dialyzed against the above buffer at 4° to 
remove excess analogue. 
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of apo-b with DPL returns the allosteric heterotropic and 
homotropic interactions characteristic of native dimer b which 
are absent in the apoenzyme. Finally, the results of Figure 9 
demonstrate that CD can be used in itself as a criterion of 
specific binding for PLP analogues with the apoenzyme. 
A number of new PLP analogues were tested in this thesis 
for their ability to bind to apo-b and cause reactivation. 
Table 2 shows spectral properties of the analogue reconstituted 
enzymes. To affect reconstitution, apo-b (7.9 mg/ml) in 0.1 M 
glycero-P, .005 M EDTA at pH 6.8 was incubated with a molarity 
of analogue equivalent to the molarity of monomer apo-b for at 
least one hour at 25°. 3-Mercaptoethanol was not included in 
these studies to prevent hemimercaptal formation with the free 
aldehyde forms of the analogues. Such forms would be expected 
to absorb in the 330 nm region and would not allow use of the 
spectrum as a means to show binding. All the analogue enzymes 
exhibited peaks in the 330 nm region. The N-methyl PLP was 
used as a control. Fischer et (1968) have reported on the 
basis of ultracentrifuge data 'that this analogue does not bind 
to the enzyme. The N-methyl PLP in the presence of apo-b gave 
a spectrum with a small, broad band near 330 nm and a more 
distinct peak at 400 nm which is characteristic of the absorp­
tion of the free compound. Although the spectral results can­
not rule out some binding of the N-methyl PLP, it is apparent 
for all other analogues tested that a substantial 330 nm band 
is formed. The small shoulders near 400 nm probably represent 
Table 2. Spectral properties of analogue reconstituted enzymes 
Analogue 4L 
1. Deoxypyridoxalyl phosphonic acid (II) 335 nm 0.505 420 nm 0.099 
2. Pyridoxal phosphate cyanoethyl ester (III) 326 nm 0.357 400 nm 0.097 
3. Pyridoxal methylphosphonic acid (IV) 330 nm 0.418 400 nm 0.158 
4. N-Methylpyridoxal phosphate 333 nm, 0.214, 
400 nm 0.219 
5. Pyridoxal phosphate 333 nm 0.534 395 nm 0.127 
a 1% \ and A refer to small shoulders in the 400 nm region, 
s s 
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either imine formation with the enzyme or unreacted analogue. 
It is tentatively concluded that all the derivatives with the 
exception of N-methyl PLP show some capacity to bind to enzyme 
and produce the characteristic band near 330 nm. 
Apo-b reconstituted with PLP N-oxide (V) gave a spectrum 
that was distinctly different than the spectra of the recon­
stituted enzymes shown in Table 2. This spectrum is shown in 
1% Figure 10; a peak at 418 nm was observed (A^^g ^ = 0.52), and 
19; 
a distinct shoulder at 322 nm was seen = 0.85). When 6ZZ nm 
spectra were taken at different times after addition of PLP 
N-oxide to apo-b, a decrease in the absorption of the free 
compound at 398 nm was observed with a parallel increase at 
322 nm and 420 nm. It would appear that both bands are formed 
at very nearly the same rate during the reaction of V with apo-
b. 
Catalytic properties 
The ability of the various analogues to reactivate apo-b 
is shown in Table 3. While it was tentatively concluded that 
all the analogues in Table 2 bind to the apoenzyme, it can be 
seen that only two of the analogues show any measuable ability 
to reactivate: the deoxypyridoxalyl phosphonic acid (II) 
showed 4% reactivation, and the PLP N-oxide (V) gave 26% re­
activation. 
From examination of space-filling models, it was found 
that the carboxymethyl side-chain of I would not extend quite 
Figure 10. Spectra of apo-b reconstituted with PLP N-oxide (V) 
Apo-b (8 mg/ml) in 0.1 M glycero-P, 0.005 M EDTA at 
pH 6.8 was reacted with a stoichiometric amount of 
V for one hr. at 30°. 
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Table 3. Activity of reconstituted enzymes 
Analogue % activity^ 
1. Carboxymethyl-deoxypyridoxal 0% 
2. Pyridoxal phosphate cyanoethyl ester 0% 
3. Pyridoxal methyl phosphonic acid 0% 
4. Deoxypyridoxalyl phosphonic acid 4% 
5. N-Oxidepyridoxal phosphate 26% 
Activities were measured in 0.05 M glycerc-P, 0.05 M 
3-ME at pH 6.8, and are expressed as % reactivation compared to 
PLP under the same conditions. 
as far as the phosphate of PLP. This might explain the in­
ability of this analogue to reactivate. However analogues III 
and IV would not have this problem. The inability of III to 
reactivate might be explained by the presence of the bulky 
cyanoethyl group. In analogue IV the substitution.of a methyl 
group for a phosphate oxygen of PLP should result in much 
smaller steric problems than found in III, but this analogue 
was also inactive. The phosphonic acid analogue (II) is the 
first analogue to be reported that gives reactivation without 
having an actual phosphate group at the 5' position. Although 
this analogue gave 4% reactivation with apo-b, it has been 
reported to give only about 0.2% reactivation to glutamic 
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oxalacetic transaminase (Furbish, 1969). This would rule out 
any possible contanimation by PLP. The observation that the 
PLP N-oxide (V) reactivates apo-b would seem to make participa­
tion of the pyridine nitrogen less likely in whatever PLP does 
to bring about the enzymic activity of phosphorylase. 
The data presented here and the previous data of other 
workers would suggest a unique role of the 5' phosphate in the 
function of PLP in phosphorylase. It would seem reasonable to 
use the normally ionized phosphate oxygen for binding purposes; 
the other phosphate oxygen could either be ionized or pro-
tonated to confer enzymic activity. Even if this were known, 
it would still not be possible to decide whether PLP is at the 
catalytic site or at another distinct site in phosphorylase. 
Such knowledge will hopefully be obtained in the near future 
from structural work. 
Reaction of apo-b-V with NH^OH 
Although the PLP N-oxide reconstituted apo-b was enzy-
matically active, the spectrum in Figure 10 indicated that a 
large portion of the bound analogue was present as an imine 
absorbing at 418 nm. The reaction of NHgOH was studied with 
apo-b-V in order to see if this imine could be removed without 
affecting the enzymic activity. Kinetics of the reaction of 
apo-b-V with NHgOH is presented in Figure 11. The reaction 
was carried out at pH 6.8 and 28° and followed by the decrease 
in absorbance at 420 nm. An A^ point was calculated by adding 
Figure 11. Kinetics of reaction of apo-b-V with NHgOH 
Apo-b-V (6.2 mg/ml), prepared as in Figure 9 
was reacted with 0.1 M NH^OH-HCl in 0.08 M 
glycero-P, 0.004 M EDTA at pH 6.8 and 28°. 
Reaction was followed at 420 nm with a Gary 15. 
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NHgOH to V and then adding the apoenzyme. In the presence of 
0.1 M NHgOH pseudo-first order kinetics were observed with a 
half-life for removal of the imine of 2.2 hr. In a separate 
experiment, using the same conditions, samples of apo-b-V were 
incubated for approximately 6 hr. in the presence and absence 
of 0.1 M NHgOH. After this time it Was found that the sample 
containing NHgOH had lost 76% of enzymic activity when compared 
to the control sample. Using the rate constant calculated 
from the experiment of Figure ii, we can calculate that 84% of 
the 418 nm imine should have reacted after 6 hr. This is in 
reasonable agreement with the observed loss of enzyme activity 
over the same time period. 
From the available results, it seems probable that the 
PLP N-oxide species absorbing at 322 nm and 418 nm in apo-b-V 
are bound at the same site. It is not possible however, to 
say which species is enzymatically active. The 418 nm species 
in apo-b-V seems to behave like the small amount of 420 nm 
species observed in the native enzyme that was discussed in an 
earlier section i.e., both imines appear to be "buried". 
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GENERAL DISCUSSION 
PLP Spectra-Structure Correlations 
in Phosphorylase 
In the literature review section of this thesis, it was 
proposed that the assignment of the 333 nm absorbing, PLP 
species in phosphorylase to a dipolar imine addition product 
might be incorrect. The tautomeric, neutral imine described 
by Heinert and Martell (1963) was also considered a good model 
to explain the available data. In particular, the neutral 
imine model was considered to be more consistent with the 
fluorescence characteristics of bound PLP in phosphorylase, in 
which a long Stokes shift had been observed. The data presented 
in this thesis can also be more easily explained by invoking 
the neutral imine model. 
The UV and the CD spectra (Figures 4, 5 and 6) of reduced 
phosphorylase b at neutral pH are all consistent with the ab­
sorption band of the substituted pyridoxamine phosphate being 
located below 300 nm. The most likely species to explain this 
observation is the tautomer of pyridoxamine in which the 3-
oxygen of the pyridine ring is protonated and the pyridine 
nitrogen is unprotonated. By studying spectra of pyridoxamine 
in methanol solution, Matsushima and Martel (1967) concluded 
that this tautomer should absorb around 290 nm; this is clearly 
consistent with the results described in this thesis on 
reduced enzyme. This spectral assignment in reduced enzyme 
would mean that the microscopic environment around the bound 
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PMP would have to be less polar than water in order for the 
neutral PMP species to be favored over the dipolar species 
found in aqueous solution. Since the reduced enzyme has 
catalytic and physical properties very similar to the native 
enzyme at neutral pH, we would expect the environment around 
the bound coenzyme to also be similar in both enzyme forms. 
In this regard, if the imine addition product of Kent (1959) 
were assumed to be the predominant species in native phos-
phorylase, it would be difficult to explain why the absorption 
should be at 333 nm. In analogy with the reduced enzyme, the 
environment around the PLP should also favor the neutral 
tautomer which would be expected to absorb at 290 nm. The 
assignment of a neutral PLP imine to the 333 nm band in the 
native enzyme, however, would allow the native and reduced 
enzymes to have the same microscopic environment around the 
bound coenzyme. 
Hedrick and Fischer (1965) have indicated that the bound 
PLP in native phosphorylase is "buried" by a number of criteria; 
chief among these being the inability of the bound coenzyme to 
react with aldehyde reagents. The same conclusion can be 
reached about the small amount of 420 nm absorbing species in 
I 
native phosphorylase. The CD results of Figure 3 indicate 
optical activity in the 420 nm absorption band of native 
enzyme. Resolution of the enzyme with NHgOH in the presence of 
a deforming buffer has previously been shown to cause a parallel 
loss in the CD of both the 333 nm and 420 nm species (Johnson 
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et al. (1968). The presence of a substantial amount of 420 nm 
imine in the spectra of apophosphorylase reconstituted with 
PLP N-oxide (Figure 10), and the slow reactivity of this 
species with NHgOH (Figure 11) again indicates an environment 
that would permit a buried imine. In terms of the proposed 
neutral imine model, the absorption in the 330 nm region and 
420 nm region found in native phosphorylase and in apoenzyme 
reconstituted with PLP N-oxide could simply result from an 
equilibrium between two imine tautomers. For the 330 nm 
species, a proton would be on the 3-oxygen of the pyridine 
ring; in the 420 nm species this proton would reside on the 
imine nitrogen. Such a scheme would allow the tautomeric 
equilibrium to exist with no enzyme conformational change 
taking place; however, equilibria between different enzyme 
conformers that would either favor the 330 nm species or the 
420 nm species cannot be ruled out. 
The chemical evidence that PLP is buried in phosphorylase 
really only indicates that the 4' carbon cannot be attacked by 
aldehyde reagents, whereas the proposed neutral imine would 
require a less polar environmejit than water around the pyridine 
ring. Bartiett (1969) in this laboratory has shown by solvent 
perturbation difference spectroscopy that PLP in phosphorylase 
is not perturbed by ethylene glycol. This would support the 
idea that the pyridine ring of the bound PLP is "tucked away". 
However, the solvent perturbation studies did show that the 
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bound PLP could be perturbed by DgO. It is doubtful, though, 
that a chromophore could be completely buried to ethylene 
glycol and completely exposed to DgO at the same time. 
Conformational Changes in Reduced Phosphorylase 
The appearance of the 332 nm band in reduced b as the pH 
is lowered could reflect a conformational change in the reduced 
enzyme. This proposal was strengthened by the results of 
Figures 6 and 7. The activator, AMP, caused a partial reversal 
at pH 6.0 in the hidden band to 332 nm conversion which would 
imply different conformations for the two spectral forms of 
reduced enzyme. The pH-dependence of activity curve also fell 
very sharply as the pH was lowered for the reduced enzyme; this 
phenomena was not seen in pH studies of the native enzyme. 
The origin of this conformational change in reduced 
enzyme is not known. It is possible that NaBH^ could have done 
more to the enzyme than just reduce the PLP; for instance, a 
peptide bond might have been reduced, but the mild conditions 
employed in the reduction would make this possibility improb­
able. Another possibility is that the PLP was not reduced ion 
the same e-amino side-chain of lysine on which is was original­
ly bound, but this change would probably cause greater observed 
differences in catalytic properties between native and reduced 
enzyme at neutral pH. Using the proposed neutral imine model 
for bound PLP in the native enzyme, reduction would cause a 
2 
change in hydridization of the 4' carbon of PLP from s£ to 
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sp^. The different steric disposition that would result 
around the 4' carbon might contribute to the observed low pH 
conformational change. 
Pyridoxal Phosphate Function in Phosphorylase 
The main approach that has been used to gain knowledge 
about the function of PLP in phosphorylase has been the 
synthesis of analogues. If PLP has a catalytic function in 
phosphorylase, there are only certain functional groups of the 
coenzyme that could be involved. Either the 3-oxygen, the 
pyridine nitrogen, or the phosphate group could act as an acid-
base catalyst at the active site. As mentioned before in the 
literature section, Fischer and Krebs (1966) reported that the 
3,0-methyl derivative of PLP was an active analogue, ruling 
out participation of the 3-oxygen in catalysis. 
The PLP N-oxide (Table 3) tested in this thesis was an 
active derivative (26%), and would likely rule out catalytic 
participation of the pyridine nitrogen. There are some pit­
falls, however: the oxygen of the N-oxide might be able to 
replace the pyridine nitrogen to some extent in a catalytic 
manner, or conceivably the PLP N-oxide might be converted to 
PLP on the enzyme. The latter possibility was not checked for, 
but in view of the data it seems unlikely. PLP in the native 
enzyme is quite refractory to NHgOH, but apoenzyme reconstituted 
with PLP N-oxide lost 76% of its activity of its activity in 
6 hr. when incubated with 0.1 M NHgOH. If this activity loss 
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were to represent attack on PLP that had arisen from PLP N-
oxide, the enzyme structure would have to have been altered to 
permit such rapid attack by NHgOH. 
The other analogues tested in this thesis involved 
changes in the 5' phosphate portion of PLP. Analogues I, III 
and IV allowed only one negative charge on the 5' side-chain 
and, while all seemed to be effective in binding, they did not 
return enzymic activity. The only active analogue was deoxy-
pyridoxalyl phosphonic acid (II) which gave 4% reactivation. 
The activity shown by this analogue intimates that either a 
second negative charge is needed on the 5' side-chain of PLP 
for interaction with the enzyme to give the active conforma­
tion, or that one of the phosphate oxygens of PLP is involved 
in acid-base catalysis. Analogue II might give only the 
observed 4% reactivation either because of a shorter 5' side-
chain than PLP, or because the pK of the phosphonic acid might 
not be close enough to the pK exhibited by the phosphate of 
PLP. A phosphonic acid analogue with a side-chain extension 
of one methylene residue might prove useful in resolving this 
question. 
The data suggesting that PLP is buried in phosphorylase 
does not preclude either a catalytic or structural function 
for the coenzyme. A conformational change could alter the 
environment of the PLP during catalysis, or if pnly the 5'-
phosphate portion were involved catalytically, the environment 
I 
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around the bound coenzyme might change very little during 
catalysis. 
From the study presented here and the cited work of many 
others, it is indeed apparent that there is still a long way 
to go in understanding the function of PLP in phosphorylase. 
Experimentally, ways must be found to locate the PLP binding 
site in relation to the catalytic binding sites in order to 
precisely determine the coenzyme function; this means that 
laborious structural work is ahead. The answer to how PLP ever 
got to be in phosphorylase in the first place, of course, lies 
in antiquity. The emerging field of biochemical evolution 
will undoubtably find the study of phosphorylase to be a 
rewarding endeavor. 
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SUMMARY 
Native Enzyme 
Phosphorylase b was shown to have a small CD band at 425 
nm in addition to the large band at 333 nm. The presence of 
phosphate (0.01 M) and AMP (0.001 M) did not perturb the 
observed long wavelength CD. 
Reduced Enzyme 
The observations of Kent (1959) that reduced b does not 
exhibit an absorption band for its substituted PMP residue at 
neutral pH, and that a 332 nm band appears at low pH were con­
firmed and extended. The 332 nm band at low pH in the reduced 
enzyme was found to be optically active, (AA/A)^ = 0.7 x 
10 ^. CD of the reduced b at pH 7.0 indicated that no new band 
was formed above 300 nm; the UV spectrum also provided no 
evidence for a PMP band above 300 nm. 
Guanidine'HCl (4.25 M) and SDS (0.3%) caused the appear­
ance of a band near 330 nm at pH 6.8. Difference spectra of 
reduced b (+ SDS; pH 5 versus pH 7) indicated that'the hidden 
band must be below 300 nm. 
! AMP (.01 M) was shown to cause partial reversal of the 
hidden band to 332 nm conversion at pH 6.0; ATP was also 
effective. Substrates and AMP had no effect on the spectrum of 
the reduced b at pH 6.8. Native b and reduced b showed dif­
ferent pH profiles of enzyme activity, with the reduced b 
activity falling off more sharply than the native b below pH 
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7.0. The data were interpreted to indicate different confor­
mations for the 332 nm and hidden band forms. 
Analogue Studies 
Apo-b reconstituted with deoxypyridoxal, pyridoxal, and 
carboxymethyl-deoxypyridoxal exhibited CD bands centered around 
330 nm. Comparison of the CD and UV spectra of apo-b reconsti­
tuted with either DPI, CMDPL, or PLP indicated that all gave 
approximately the same CD when corrected for the amount of 
analogue bound. 
All the analogues tested gave a band near 330 nm when re­
acted with stoichiometric amounts of apo-b. Carboxymethyl-
deoxypyridoxal (I), PLP cyanoethyl ester (III) and pyridoxal 
methylphosphonic acid (IV) all failed to reactivate apo-b. De-
oxypyridoxalyl-phosphonic acid (II) gave 4% reactivation of 
apo-b, and PLP N-oxide (V) gave 26% reactivation when compared 
with PLP. 
The PLP N-oxide enzyme showed a substantial imine maximum 
at 418 nm and a distinct shoulder at 322 nm. Apo-b-V was re­
acted with NHgOH (0.1 M) at pH 6.8 and 28°. Disappearance of 
the imine at 420 nm showed pseudo-first order kinetics with an 
observed half life of 2.2 hr. Loss of enzyme activity paral­
leled the loss of the imine. 
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Spectra-Structure Correlation 
From the results obtained with the reduced b, a neutral 
tautomer of the substituted PMP, absorbing near 290 nm, was 
assigned to the hidden band. The 332 nm species in reduced b 
was postulated to arise from a conformational change at low 
pH that exposed the PMP residue to a more polar environment. 
In analogy with reduced b, the species absorbing at 333 
nm in native b was assigned to be a neutral imine tautomer 
(imine-nitrogen unprotonated and 3-oxygen protonated). The 
neutral imine tautomer was postulated to be in an environment 
less polar than water. Tautomerization of the neutral imine 
was postulated to explain the unreactive 420 nm imines in 
native b and apo-b-V. 
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